Significant and decreased concentrations of fibronectin were also observed in children with upper or lower respiratory tract infections (p = 0.0002). On the other hand, serum fibronectin receptor concentrations were significantly increased in patients with pertussis, whereas patients with upper or lower respiratory tract infections had normal circulating fibronectin receptor concentrations. Conclusions-Fibronectin deficiency in children with pertussis may be related to diffusion and deposition of this protein in bronchial and alveolar spaces to limit infection, while increased fibronectin receptor concentrations are probably the expression of study. Table 2 indicates the fibronectin concentrations in eight children with pertussis. As can be seen, a significant decrease in fibronectin was observed in these patients (p = 00006). Patients with acute upper or lower respiratory tract infections had decreased fibronectin concentrations as well (p = 00002). Table 3 shows the fibronectin concentrations in six children with pertussis, who were followed up for 15 days. As shown, a moderate but not significant increase in fibronectin concentrations was noted 15 days after admission (ANOVA test: p = 03742). Table 4 shows the serum concentrations of fibronectin receptor in patients with pertussis and in those with acute upper or lower respiratory tract infections. A significant increase in serum fibronectin receptor concentrations was observed in patients with pertussis (p = 00003). On the other hand, patients with acute respiratory tract infections had normal serum fibronectin receptor concentrations.
Discussion
The results of our study show that fibronectin concentrations were significantly reduced in children with pertussis; in contrast, serum fibronectin receptor concentrations were increased in the same patients. Monocytes and macrophages bind fibronectin and such proteins have been reported to enhance the phagocytosis of gelatin-coated erythrocytes.2'
The decreased fibronectin concentrations observed in our patients could be related to opsonisation activity with a probable consumption of fibronectin itself. On the other hand, fibronectin may have a role in the pulmonary colonisation and infection caused by B pertussis. During B pertussis infection, in view of local abundance of fibronectin in bronchial and alveolar spaces, binding of fibronectin to B pertussis might assist attachment to bronchial and alveolar epithelial cells. Fibronectin, acting as an opsonin, may bind B pertussis through its adhesive sequence in bronchial and alveolar spaces. Such opsonic binding can lead to consumption of fibronectin in order to stimulate phagocytosis and killing of B pertussis and thus to limit colonisation and consequent infection. In this case fibronectin deficiency in children with pertussis as well as in those with acute bacterial respiratory tract infection may be due to diffusion and deposition of fibronectin into areas of inflammation, and in particular, within bronchial and alveolar spaces, to limit or block bacterial infection.
Fibronectin receptor belongs to an "integrin superfamily", and as a serum integrin, is involved in specific adhesive interaction between mononuclear cells and extracellular matrix.2' Fibronectin receptor has also been identified as very late antigen-5 (VLA-5) of the VLA integrin family. VLA-5 integrins are expressed in activated human T cells as well as in many other cell types, including monocyte/macrophages. In recent years the role of cell mediated immunity in protection against B pertussis infection has been investigated thoroughly. Several investigators have shown that a strong T cell mediated reactivity to B pertussis bacteria develops in mice after aerosol infection.2425 In particular, B pertussis specific T cells induced by infection in mice are confined to the CD4 positive T cell subpopulation.'6 Increased serum concentrations of circulating fibronectin receptor in children with pertussis may be related to expression and release of such integrin from human T cells activated by whole B pertussis bacteria, or its components, including pertussis toxin, filamentous haemagglutinin, agglutinogens and pertactin.
In conclusion, the multiple biological functions of fibronectin suggest a role for it as a defence protein in the early phase of infection. In contrast, due to its interaction with microorganisms, fibronectin is also potentially important in the adherence of bacteria to epithelial cells and in the establishment of respiratory infection. However, further studies are needed to elucidate the role of fibronectin in binding B pertussis, allowing alveolar macrophages to phagocytise and kill efficiently the organism.
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